People are paying for the research no one else will compile.
"I had a mild infection in early 2022. By summer I couldn't walk up the stairs without my heart rate hitting 160. Three doctors told me it was deconditioning and to exercise more. I got worse every time I tried. I just wanted someone to read the actual research on POTS and dysautonomia post-COVID and tell me what's worth asking my cardiologist about."
— Rachel, post-COVID dysautonomia
"Brain fog is destroying my career. My PCP shrugged. The neurologist said 'wait it out.' I've been waiting two years. Reading PubMed at 2am isn't a sustainable plan but it's what I've been doing because nobody on my care team will."
— Marcus, Long COVID with cognitive symptoms
This is for Rachel. And Marcus. And every Long COVID patient who has been told it's anxiety, deconditioning, or just stress — and knows it isn't.
What you'll get back
Sample findings from a brief like yours. Each rated by how many specialists converged on the evidence.
Promising
POTS, Dysautonomia & Heart-Rate-Capped Reconditioning
Post-COVID POTS is now well-recognized in the cardiology and dysautonomia literature. Standard exercise recommendations make most patients worse. Published heart-rate-capped reconditioning protocols (CHOP, Levine) are designed specifically for dysautonomia and have meaningful improvement signals when adherence is supported. Workups include tilt-table or 10-minute stand, plasma volume, and cortisol response.
Question to bring to your cardiologist or autonomic specialist: should we run a 10-minute stand or tilt-table test, and would a heart-rate-capped reconditioning protocol be appropriate before generic 'exercise more' advice?
Emerging
Microclot, Endothelial Dysfunction & Targeted Anticoagulation
Microclot and persistent endothelial dysfunction signatures in Long COVID have a growing body of peer-reviewed evidence. Several research groups have piloted triple anticoagulation protocols and selective antiplatelet therapy in symptomatic patients with elevated D-dimer or fibrinogen. Trial data is small and early; risk/benefit is highly individual and requires hematology coordination.
Question to bring to your physician: is there a hematology workup (D-dimer, fibrinogen, microclot panel) that's reasonable given my symptom profile, and is there a specialist locally who follows the published Long COVID anticoagulation literature?
Emerging
Mitochondrial Dysfunction & Targeted Cofactor Support
Mitochondrial dysfunction signatures (impaired oxygen extraction on iCPET, lactate kinetics) are documented in Long COVID with PEM and chronic fatigue. CoQ10, NAD+ precursors, l-carnitine, and structured pacing protocols have small-clinical and case-series evidence. Effect sizes are modest; safety profiles are well-established when dosed to labs.
Question to bring to your physician: would a mitochondrial-function workup (iCPET if available, basic lactate/lipid panel) be informative, and which cofactors have the strongest evidence for my specific symptom cluster?
Sample findings shown are representative of the structure your brief will follow. Yours is tailored to the specific question you submit.
Why $99
At a top academic center — Mayo Clinic, MD Anderson, Cleveland Clinic — your case might be reviewed by 5-7 sub-specialists in a tumor board. That access takes weeks of referrals, often travel, and runs $2,000–$5,000 just for the consult.
Insight Swarm convenes 14 specialist agents for your case. Same shape of analysis. 48 hours instead of 6 weeks. $99 instead of $5,000+.